847729-04-8

Basic information

• Product Name: Benzoic acid,4-[(1S)-1-[[(2,5-dichloro-3-pyridinyl)carbonyl]amino]ethyl]-,1,1-dimethylethyl ester
• CAS NO: 847729-04-8
• Molecular Formula: C19H20Cl2N2O3
• Molecular Weight: 395.285
• Mol File: 847729-04-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid,4-[(1S)-1-[[(2,5-dichloro-3-pyridinyl)carbonyl]amino]ethyl]-,1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid,4-[(1S)-1-[[(2,5-dichloro-3-pyridinyl)carbonyl]amino]ethyl]-,1,1-dimethylethyl ester(847729-04-8)
• EPA Substance Registry System: Benzoic acid,4-[(1S)-1-[[(2,5-dichloro-3-pyridinyl)carbonyl]amino]ethyl]-,1,1-dimethylethyl ester(847729-04-8)

Safety Data

• Hazardous Substances Data: 847729-04-8(Hazardous Substances Data)

Upstream product

• 222714-33-2 4-[(1S)-1-aminoethyl]benzoic acid 
• 847729-01-5 (S)-tert-butyl 4-[1-(benzyloxycarbonylamino)ethyl]benzoate 
• 847729-00-4 (S)-4-[1-(benzyloxycarbonylamino)ethyl]benzoic acid 
• 847729-02-6 tert-butyl 4-[(1S)-1-aminoethyl]benzoate 
• 59782-85-3 2,5-dichloronicotinic acid 

Downstream Products

• 847727-81-5 4-[(1S)-1-({[5-chloro-2-(3-fluorophenoxy)pyridin-3-yl]carbonyl}amino)ethyl]benzoic acid 
• 847727-77-9 4-[(1S)-1-({[5-chloro-2-(4-fluorophenoxy)pyridine-3-yl]carbonyl}amino)ethyl]benzoic acid 
• 868635-68-1 tert-butyl 4-[(1S)-1-({[5-chloro-2-(3-chlorophenoxy)pyridin-3-yl]carbonyl}amino)ethyl]benzoate 
• 868635-67-0 tert-butyl 4-[(1S)-1-({[5-chloro-2-(3-fluorophenoxy)pyridin-3-yl]carbonyl}amino)ethyl]benzoate 

Relevant articles and documents

Discovery of AAT-008, a novel, potent, and selective prostaglandin EP4 receptor antagonist

Starting from acylsufonamide HTS hit 2, a novel series of para-N-acylaminomethylbenzoic acids was identified and developed as selective prostaglandin EP4 receptor antagonists. Structural modifications on lead compound 4a were explored with the aim of impr

COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS

The instant invention relates to a combination of an EP4-receptor antagonist and an alpha-2-delta ligand, and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof and their use in the treatment of pain, particularly inflammatory,